Get started

Runner

ObsEva, emerging company on verge of phase 3 completion Hi Ya'll, I hope you're having a Good Friday night. I came across this gem yesterday and I have to give it a shout out. ObsEva is a unique company, and has lots of potential. They have three drugs currently in pipelines. Its recently broken out and is channeling upward and moving very healthily. I have a price target of $10+. With a long term hold. Yselty- Phase 3 Ebopripant - Phase 2 Nolasiban -Phase 1 www.obseva.com Yselty is about to be finished testing. It looks positive and ready to be sold world wide. This product is very good for dealing with uterary fibroids which is very common and has no clear medication to use to solve it. If y'all can post your own understanding of the significance of these drugs I would appreciate it. I do not fully understand what these drugs do but they seem to be a big deal. Many analysts have set price targets ranging from $4.00-$28.00 a share. I will link this. www.tipranks.com Please give the company corporate presentation a look, and please tell me if I missed anything crucial, like the executives, etc.. www.obseva.com Thanks, Benjamin
OLong
by benarcotta
1
One GREAT Trade a Day Is All You Need - DT RECAP 04/27/20Hi traders, Today I kind of repeated Friday - only one trade, but a great winner! If you take a look at the ticker, I could've got +4% out of it. Am I mad? NO!! I already got way more than I aimed for. Greed will not make you profitable. My trade: 1) NYSE:C - LONG @45.02 , I was cautious about the 45.60 area of the previous swing high, but seeing Citigroup's strength and overall markets upwards direction led me to hold it even further. +2.82% *In my ID trades, I risk 1% of the account per trade and go for 2% (2:1 RRR ). Sometimes I adapt a little bit as you can see in the trades' description.* Total PnL for the day: +2.82% Total PnL for the week: +2.82% Good trades, Tom | FINEIGHT
AMEX:SPY
by Fineight
BTCUSD: Resistance Zone Is First Profit Opportunity?BTCUSD update: Bullish momentum is in effect as price reaches the 9887 to 10836 resistance zone, coming off of the recent higher low formation. This is where the herd begins to get excited, and also where the first profit target should be considered for swing trades. On 2/11/18 I highlighted a swing trade that triggered on the break of the 8570 candle high (I got filled at 8690, it's in the report). I am holding for a broader move, but for those who were more interested in a swing trade (short term move, defined stop and target), the first target area is about 650 points away. The 9887 to 10836 is the first resistance zone (.618 of recent bearish swing), that is being tested since the sell off. The swing trade target that I highlighted is the 10500 level which is basically in the middle of the zone. Why sell if this market still has a lot of room to run? This is the first level to consider locking in SOME profit, not your entire position. IF you got long around the 8690 level, you are up almost 1200 points at the moment. and at 10,500 you would be up 1800. Not bad for 5 days, so why not lock some in? It reduces risk and allows you to outperform the buy and hold strategy in an environment that is not the most stable. Remember the herd mentality. When markets start breaking resistances and pushing highs, the crowd reacts. This type of reaction, which is now in the form of strength is an opportunity for those who were able to anticipate this move to sell into strength. This is a best practice and the only obstacle in your way is greed. What about the bigger picture trade though? This is where your perspective, outlook and risk tolerance come into play. The positions that I built as this market bottomed were part of a position trade. I did not use any stops or targets because my outlook is anticipating the broader trend to reassert itself. For my trade, that scenario would be confirmed upon the break of the bearish trend line that was established in January. This would put price around the 12K area. As I hold out for these possibilities, I am taking more risk. The market can turn back at any moment and retest the 8Ks or even lower IF this market goes into a range bound scenario. So with that said, for my position trade, I intend to lock in SOME profit IF we reach the trend line and get a bearish reversal candle. If on the other hand, price blows through, then there is no reason to sell until the next resistance takes hold which can be in the high 13Ks. If I am going to lock in some profit, I at least want to make sure I have given the market a chance to maximize it. Another way to do this is to use a manual trailing stop which you place at the low of the previous candle. This is a good technique for when you have reached an acceptable profit target, and there is no reason to sell. Just trail the stop and let the market take you out. In summary, hopefully from the series of my previous reports, you can piece together the process that I covered to build my long position trade in this market. Now that we are at a resistance, I have the luxury I deciding if I want to lock in some profit or hold to see if my bigger picture anticipation plays out. The key point is: from start to finish I have been following a plan and NOT reacting to anything. At the current resistance area, best practices tell me that this is an area to consider locking in profit, and NOT buying. If you missed all the buying opportunities that I have been writing about, and you buy now, you are taking much greater risk and buying into a resistance level. This area is an opportunity for people who want to lock in some profit, not initiate new positions. A break of the current bullish trend line will negate this momentum, so be mindful of that and manage your risk carefully. Otherwise, besides locking some in, the other best practice is let winners run. That is my plan until broader resistance levels are in play. Questions and comments welcome.
BITFINEX:BTCUSD
by MarcPMarkets
27
FDA Approval "coming soon"From a post on ihub- an investor emailed investor relations and received this response $$$ to: info@viadermalicensing.com cc: sales@viadermalicensing.com subject: Update mailed-by: gmail.com Hello, I have a few questions: 1-Can we expect a PR with a FDA approval this week or next for your product for treating Premature Ejaculation? 2-Are sales rolling out this quarter for Viabecline? 3-Will the lawsuit be dropped or settled this quarter? Will ViaDerma prevail? 4-Hasn't the efficacy already been done for Viabecline? Why have you started a new independent study in Texas to prove Viabecline's efficacy in treating diabetic foot wounds? 5-How much revenue do you expect from the grass roots THC and non-THC Cannabinoids, both in a patch form, roll on and spray signed with the Canadian company? Are your plans to sell licensing agreements to major producers? Thank you ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ info@viadermalicensing.com 3:08 PM (17 hours ago) FDA approval is on track. No delays are expected. Stand by for updates on that Rollout is also still on time and should be out by the of the quarter (one month from now) We received a continuance to submit our reply to the lawsuit. That's usually pretty standard. We will report developments as they happen but we feel very strongly we will prevail. We cant say too much until after we file our official reply with the court Efficacy has been done but the reason for the independent study is to show we do it better. Can't answer any revenue guidance question yet until we release that to the public. Hopefully soon. Stay tuned for more news in the near future. We expect to report on some of these and other developments shortly. Thanks Investor Relations (310) 734 6111
OTC:VDRMLong
by Cryptocol
Cash bleeding company on a bullish trend how far can this run?PLSE has been bleeding cash for a while now but it has attracted investments from two investors providing cash infusion to help it stay afloat on early February. This is when the stock broke out and has been trending up since then. Even though doom and gloom was predicted for PLSE here on Feb 23 2017 stock has moved up by $7 since then. Yesterday I was expecting a pull back to $18 or a $22 to hold and rip. Now some sort of consolidation would be necessary or else this will get shorted aggressively. Originally posted in : blog.buysellshortcover.com
NASDAQ:PLSE
by Saadey